- iCrowdNewswire
  • Spain
  • Brazil
  • Russia
  • France
  • Germany
  • China
  • Korea
  • Japan

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Europe ( XML Feed )
United States ( XML Feed )

Nov 10, 2017 4:20 PM ET

Hemophilia Market Analysis

iCrowdNewswire - Nov 10, 2017

The Global Hemophilia Market Report: 2016 Edition research of 52 pages with 47 Charts and 2 Tables to the pharmaceuticals industry segment of its online data and intelligence library. Complete report available at http://www.marketreportsonline.com/463723.html.


Hemophilia refers to a set of hereditary genetic disorders that impairs the body’s ability to control blood clotting, which controls bleeding when a blood vessel is broken. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. In the absence of a treatment, uncontrolled internal bleeding can occur, causing stiffness, pain, severe joint damage and even death. Depending upon the coagulation factor deficiency, there are different types of hemophilia such as Hemophilia A, Hemophilia B, Hemophilia C, Von Willebrand disease and Hemophilia with Inhibitors.


Even though Hemophilia is rare bleeding disorder, the number of people affected by it has been increasing with time. While mild hemophilia is easy to diagnose especially in kids, when they learn to move and walk, and get large bruises from minute falls, severe hemophilia patients need to go for periodic transfusion of the respective factors so as to avoid the event of life-threatening bleeding episodes. Such a periodic transfusion is done through what is commonly known as the replacement therapy. With increasing sophistication and modernization of technology, demand for advanced treatment options increases, thereby making the entire market grow.


The key factors which are anticipated to drive this market include increasing penetration of recombinant factor VIII, increasing healthcare expenditure, emerging use of treatments in low income countries and increasing diagnosis rates. Some of the noteworthy progresses of this industry include the increasing adoption of prophylaxis therapy, introduction of extended half-life products and gene therapy. However, the growth of respective industry is challenged by the high cost of treatments and high reluctance by patients to switch to new treatments/products.


The report provides a comprehensive study of global hemophilia market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. The global hemophilia industry is highly competitive consisting of several large companies including the Shire Plc, Bayer Group, Pfizer Inc, Novo Nordisk etc. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.


Purchase a copy of this Hemophilia Market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=463723.


Company Coverage of Hemophilia Market: Shire PLC, Bayer Group, Novo Nordisk & Pfizer Inc.


Few Points from List of Charts Provided in Hemophilia Market:

Types of Hemophilia

Global Hemophilia Prevalence (2015)

Global Hemophilia Diagnosis and Treatment Ratio (2015)

Global Hemophilia Market Revenue (2015E-2020F)

Global Hemophilia Revenue Share by Category (2015E)

Global Hemophilia Revenue Share by Category –Forecast (2020)

Global FVIII Demand by Volume (2011-2015E)

Global FVIII Demand by Category – Volume (2015E-2017E)

Global Supply Capacity of Recombinant FVIII – Actual (2011-2015E)

Global Supply Capacity of Recombinant FVIII – Forecast (2016F-2017F)

Global Hemophilia A Market Revenue (2015E-2020F)

Global Hemophilia A Revenue Share by Category (2015E)

Global Hemophilia B Market Revenue (2015E-2020F)

Global Hemophilia with Inhibitors Market Revenue (2015E-2020F)

The US Hemophilia Patients Treated per Year (2013-2020F)

The US Hemophilia Market Revenue (2013-2015E)

The US Hemophilia Market Revenue – Forecast (2016F-2020F)

The US Hemophilia A Patients Treated per Year (2013-2020F)

The US Hemophilia A Market Revenue (2013-2020F)

The US Hemophilia B Patients Treated per Year (2013-2020F)

The US Hemophilia B Market Revenue (2013-2020F)

The US Hemophilia with Inhibitors Patients Treated per Year (2013-2020F)

The US Hemophilia with Inhibitors Market Revenue (2013-2020F)

The US Von Willebrand Factor Market Revenue (2013-2020F)


Browse All Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.


About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Information:

Contact Us:
Hrishikesh Patwardhan
Tel: + 1 888 391 5441
E-mail: [email protected]

View Related News >